Zevra Therapeutics Inc (ZVRA)
8.60
+0.02
(+0.23%)
USD |
NASDAQ |
Dec 24, 11:13
Zevra Therapeutics Shareholders Equity (Quarterly): 69.77M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 662.47M |
| Johnson & Johnson | 70.16B |
| Vanda Pharmaceuticals Inc | 541.22M |
| Zoetis Inc | 5.234B |
| Xeris Biopharma Holdings Inc | -28.32M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 191.55M |
| Total Liabilities (Quarterly) | 121.78M |
| Debt to Equity Ratio | 0.8443 |
| Current Ratio | 2.884 |
| Net Debt Paydown Yield | -2.50% |